Muscarinic modulation of neurotransmission: The effects of some agonists and antagonists

L. Re, V. Cola, G. Fulgenzi, F. Marinelli, C. Concettoni, L. Rossini

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

1. 1. Functional studies were performed to evaluate the effects of some muscarinic agents at the neuromuscular junction of the mouse. 2. 2. The presynaptic control of acetylcholine release and the postsynaptic activation of the nicotinic receptor have been analyzed by means of extracellular recording. The amplitude of spontaneous and of evoked acetylcholine release, the frequency of spontaneous acetylcholine release and the time course of the quantal release have been measured by means of an EPC7 patch clamp amplifier. 3. 3. This electrophysiological method revealed multiple dose-related effects of some agonists and antagonists on the above parameters. Concentration-response curves related to the parameters underlying the function of this cholinergic synapse were obtained and the apparent EC50 values calculated. 4. 4. Many of the interactions of the agonists and antagonists could inhibit neuromuscular transmission. The rank order potencies related to the inhibition of the evoked signals were carbachol > oxotremorine > d,l-muscarine for the agonists and methoctramine > 4-DAMP > l-hyoscyamine > AFDX-116 > ipratropium > pirenzepine for the antagonists. 5. 5. These findings suggest a more complicated pattern related to the muscarinic action at the mouse neuromuscular junction with the involvement of some post-synaptic located sites.

Original languageEnglish
Pages (from-to)1447-1453
Number of pages7
JournalGeneral Pharmacology
Volume24
Issue number6
DOIs
Publication statusPublished - 1993

Fingerprint

Synaptic Transmission
Cholinergic Agents
Acetylcholine
Neuromuscular Junction
Hyoscyamine
Muscarine
Oxotremorine
Ipratropium
Pirenzepine
Nicotinic Receptors
Carbachol
Synapses
4-diphenylacetoxy-1,1-dimethylpiperidinium
methoctramine
otenzepad

ASJC Scopus subject areas

  • Pharmacology

Cite this

Re, L., Cola, V., Fulgenzi, G., Marinelli, F., Concettoni, C., & Rossini, L. (1993). Muscarinic modulation of neurotransmission: The effects of some agonists and antagonists. General Pharmacology, 24(6), 1447-1453. https://doi.org/10.1016/0306-3623(93)90433-X

Muscarinic modulation of neurotransmission : The effects of some agonists and antagonists. / Re, L.; Cola, V.; Fulgenzi, G.; Marinelli, F.; Concettoni, C.; Rossini, L.

In: General Pharmacology, Vol. 24, No. 6, 1993, p. 1447-1453.

Research output: Contribution to journalArticle

Re, L, Cola, V, Fulgenzi, G, Marinelli, F, Concettoni, C & Rossini, L 1993, 'Muscarinic modulation of neurotransmission: The effects of some agonists and antagonists', General Pharmacology, vol. 24, no. 6, pp. 1447-1453. https://doi.org/10.1016/0306-3623(93)90433-X
Re, L. ; Cola, V. ; Fulgenzi, G. ; Marinelli, F. ; Concettoni, C. ; Rossini, L. / Muscarinic modulation of neurotransmission : The effects of some agonists and antagonists. In: General Pharmacology. 1993 ; Vol. 24, No. 6. pp. 1447-1453.
@article{315c75f7e1454575a9c42747f7e78ce2,
title = "Muscarinic modulation of neurotransmission: The effects of some agonists and antagonists",
abstract = "1. 1. Functional studies were performed to evaluate the effects of some muscarinic agents at the neuromuscular junction of the mouse. 2. 2. The presynaptic control of acetylcholine release and the postsynaptic activation of the nicotinic receptor have been analyzed by means of extracellular recording. The amplitude of spontaneous and of evoked acetylcholine release, the frequency of spontaneous acetylcholine release and the time course of the quantal release have been measured by means of an EPC7 patch clamp amplifier. 3. 3. This electrophysiological method revealed multiple dose-related effects of some agonists and antagonists on the above parameters. Concentration-response curves related to the parameters underlying the function of this cholinergic synapse were obtained and the apparent EC50 values calculated. 4. 4. Many of the interactions of the agonists and antagonists could inhibit neuromuscular transmission. The rank order potencies related to the inhibition of the evoked signals were carbachol > oxotremorine > d,l-muscarine for the agonists and methoctramine > 4-DAMP > l-hyoscyamine > AFDX-116 > ipratropium > pirenzepine for the antagonists. 5. 5. These findings suggest a more complicated pattern related to the muscarinic action at the mouse neuromuscular junction with the involvement of some post-synaptic located sites.",
author = "L. Re and V. Cola and G. Fulgenzi and F. Marinelli and C. Concettoni and L. Rossini",
year = "1993",
doi = "10.1016/0306-3623(93)90433-X",
language = "English",
volume = "24",
pages = "1447--1453",
journal = "General Pharmacology: The Vascular System",
issn = "0306-3623",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Muscarinic modulation of neurotransmission

T2 - The effects of some agonists and antagonists

AU - Re, L.

AU - Cola, V.

AU - Fulgenzi, G.

AU - Marinelli, F.

AU - Concettoni, C.

AU - Rossini, L.

PY - 1993

Y1 - 1993

N2 - 1. 1. Functional studies were performed to evaluate the effects of some muscarinic agents at the neuromuscular junction of the mouse. 2. 2. The presynaptic control of acetylcholine release and the postsynaptic activation of the nicotinic receptor have been analyzed by means of extracellular recording. The amplitude of spontaneous and of evoked acetylcholine release, the frequency of spontaneous acetylcholine release and the time course of the quantal release have been measured by means of an EPC7 patch clamp amplifier. 3. 3. This electrophysiological method revealed multiple dose-related effects of some agonists and antagonists on the above parameters. Concentration-response curves related to the parameters underlying the function of this cholinergic synapse were obtained and the apparent EC50 values calculated. 4. 4. Many of the interactions of the agonists and antagonists could inhibit neuromuscular transmission. The rank order potencies related to the inhibition of the evoked signals were carbachol > oxotremorine > d,l-muscarine for the agonists and methoctramine > 4-DAMP > l-hyoscyamine > AFDX-116 > ipratropium > pirenzepine for the antagonists. 5. 5. These findings suggest a more complicated pattern related to the muscarinic action at the mouse neuromuscular junction with the involvement of some post-synaptic located sites.

AB - 1. 1. Functional studies were performed to evaluate the effects of some muscarinic agents at the neuromuscular junction of the mouse. 2. 2. The presynaptic control of acetylcholine release and the postsynaptic activation of the nicotinic receptor have been analyzed by means of extracellular recording. The amplitude of spontaneous and of evoked acetylcholine release, the frequency of spontaneous acetylcholine release and the time course of the quantal release have been measured by means of an EPC7 patch clamp amplifier. 3. 3. This electrophysiological method revealed multiple dose-related effects of some agonists and antagonists on the above parameters. Concentration-response curves related to the parameters underlying the function of this cholinergic synapse were obtained and the apparent EC50 values calculated. 4. 4. Many of the interactions of the agonists and antagonists could inhibit neuromuscular transmission. The rank order potencies related to the inhibition of the evoked signals were carbachol > oxotremorine > d,l-muscarine for the agonists and methoctramine > 4-DAMP > l-hyoscyamine > AFDX-116 > ipratropium > pirenzepine for the antagonists. 5. 5. These findings suggest a more complicated pattern related to the muscarinic action at the mouse neuromuscular junction with the involvement of some post-synaptic located sites.

UR - http://www.scopus.com/inward/record.url?scp=0027333080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027333080&partnerID=8YFLogxK

U2 - 10.1016/0306-3623(93)90433-X

DO - 10.1016/0306-3623(93)90433-X

M3 - Article

C2 - 8112518

AN - SCOPUS:0027333080

VL - 24

SP - 1447

EP - 1453

JO - General Pharmacology: The Vascular System

JF - General Pharmacology: The Vascular System

SN - 0306-3623

IS - 6

ER -